Global Drugs & Biologics Update
February 24, 2015
North America |
| Canada |
TPD – Therapeutic Products Directorate |
| Safety Information |
Post-marketing approval information updated |
The post-authorization activity update covers Almiral’s bronchodilator Genuair Tudorza, and relates to additions that were made to the warnings and precautions and adverse reactions sections of product labeling. |
| Close this Window |